This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berling, M.
Right arrow Articles by Lopez-Ferber, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berling, M.
Right arrow Articles by Lopez-Ferber, M.
Agricola
Right arrow Articles by Berling, M.
Right arrow Articles by Lopez-Ferber, M.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, February 2009, p. 925-930, Vol. 75, No. 4
0099-2240/09/$08.00+0     doi:10.1128/AEM.01998-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Cydia pomonella granulovirus Genotypes Overcome Virus Resistance in the Codling Moth and Improve Virus Efficiency by Selection against Resistant Hosts{triangledown}

Marie Berling,1 Christine Blachere-Lopez,1 Olivier Soubabere,2 Xavier Lery,3 Antoine Bonhomme,2 Benoît Sauphanor,4 and Miguel Lopez-Ferber1*

EMA, Centre LGEI, 6 Avenue de Clavières, 30100 Alès, France,1 NPP (Arysta LifeScience), 35 Avenue Léon Blum, 64000 Pau, France,2 IRD, 158 Avenue Charles de Gaulle, 30380 St. Christol-les-Alès, France,3 INRA, Unité PSH, Agroparc, 84914 Avignon Cedex 9, France4

Received 28 August 2008/ Accepted 17 December 2008

Cydia pomonella granulovirus (CpGV) has been used for 15 years as a bioinsecticide in codling moth (Cydia pomonella) control. In 2004, some insect populations with low susceptibility to the virus were detected for the first time in southeast France. RGV, a laboratory colony of codling moths resistant to the CpGV-M isolate used in the field, was established with collection of resistant insects in the field followed by an introgression of the resistant trait into a susceptible colony (Sv). The resistance level (based on the 50% lethal concentrations [LC50s]) of the RGV colony to the CpGV-M isolate, the active ingredient in all commercial virus formulations in Europe, appeared to be over 60,000-fold compared to the Sv colony. The efficiency of CpGV isolates from various other regions was tested on RGV. Among them, two isolates (I12 and NPP-R1) presented an increased pathogenicity on RGV. I12 had already been identified as effective against a resistant C. pomonella colony in Germany and was observed to partially overcome the resistance in the RGV colony. The recently identified isolate NPP-R1 showed an even higher pathogenicity on RGV than other isolates, with an LC50 of 166 occlusion bodies (OBs)/µl, compared to 1.36 x 106 OBs/µl for CpGV-M. Genetic characterization showed that NPP-R1 is a mixture of at least two genotypes, one of which is similar to CpGV-M. The 2016-r4 isolate obtained from four successive passages of NPP-R1 in RGV larvae had a sharply reduced proportion of the CpGV-M-like genotype and an increased pathogenicity against insects from the RGV colony.

* Corresponding author. Mailing address: Centre LGEI, Ecole des Mines d'Alès, 30319 Alès, France. Phone: 33466782704. Fax: 33466783701. E-mail: Miguel.Lopez-Ferber{at}ema.fr

{triangledown} Published ahead of print on 29 December 2008.

Applied and Environmental Microbiology, February 2009, p. 925-930, Vol. 75, No. 4
0099-2240/09/$08.00+0     doi:10.1128/AEM.01998-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»